European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. | Zendy

Juhani Sivenius | Zendy; Markku Laakso | Zendy; P. Riekkinen | Zendy; P. Smets | Zendy; A. Löwenthal | Zendy

Open Access

European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.

Author(s) -

Juhani Sivenius,

Markku Laakso,

P. Riekkinen,

P. Smets,

A. Löwenthal

Publication year - 1992

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.23.6.851

Subject(s) - medicine , dipyridamole , stroke (engine) , diabetes mellitus , placebo , cerebral infarction , clinical endpoint , aspirin , cardiology , surgery , clinical trial , ischemia , endocrinology , pathology , engineering , mechanical engineering , alternative medicine

The European Stroke Prevention Study was a multicenter trial comparing the effect of a combination of 75 mg dipyridamole and 330 mg acetylsalicylic acid three times a day with the effect of a placebo in the prevention of stroke or death in 1,861 patients after one or more episodes of recent transient ischemic attack or cerebral infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research